Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Hepatitis C 4Carcinoma, Hepatocellular 3Respiratory Tract Infections 2Leukemia, Myeloid, Acute 2Respiratory Syncytial Virus Infections 1Recurrence 1Pneumonia 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Liver Neoplasms 1Liver Diseases 1Infections 1Hepatitis 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1Bronchiolitis Obliterans Syndrome 1

Interventions

Ribavirin 2tocilizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Respiratory Tract Infections × Ribavirin × Clear all
NCT01502072 2021-02-15

Respiratory Syncytial Virus - RSV Protocol

M.D. Anderson Cancer Center

Phase 2 Completed
48 enrolled 11 charts

Neoplasms, Pneumonia, Respiratory Tract Infections, Respiratory Syncytial Virus Infections

NCT00500578 2012-08-01

Intermittent Use of Aerosolized Ribavirin for Treatment of RSV

M.D. Anderson Cancer Center

Phase 4 Completed
51 enrolled 8 charts
Other hematologic neoplasm

Respiratory Tract Infections, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡